EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers

Fan Zhang, Gen Chen, Mengqi Huang, Yang Yang, Zixiong Wang, Yaqi Shen iD, Yan Luo, Xuemei Hu iD, Zhen Li iD

Journal of Hepatocellular Carcinoma · 2026-02 · Volume 13 · 1-14

DOI: 10.2147/jhc.s574222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-02. Verfasst von Fan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of C…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to develop and validate a noninvasive multiparametric magnetic resonance imaging (MRI) model integrating hepatobiliary-phase T1 mapping (T1HBP), tumor-to-liver R2-star ratio (TLRR2*), and clinical biomarkers to predict high Ki-67 expression (>30%) in patients with hepatocellular carcinoma (HCC). Patients and Methods: In this retrospective study, 60 patients with histopathologically confirmed HCC who underwent preoperative multiparametric MRI-including T1 mapping, proton density fat fraction (PDFF), and R2-star sequences-were enrolled. Based on immunohistochemical analysis, patients were classified into high (n=22) and low (n=38) Ki-67 expression groups. Clinical data and quantitative MRI parameters were compared between groups. Univariate and multivariate logistic regression analyses were conducted to identify independent predictors of high Ki-67 expression. The diagnostic performance of each parameter and the combined model was evaluated using receiver operating characteristic (ROC) curve analysis.

Results

Multivariate analysis identified serum total bilirubin (TBil; OR=1.109, p=0.032), T1HBP (OR=1.004, p=0.026), and TLRR2* (OR=5.428, p=0.034) as independent predictors of high Ki-67 expression. The multiparametric model incorporating TBil, T1HBP, and TLRR2* achieved superior predictive performance, with an area under the ROC curve (AUC) of 0.813 (95% CI: 0.704-0.923), significantly outperforming individual parameters (T1HBP AUC=0.682, TLRR2* AUC=0.671, TBil AUC=0.664; all p 0.80).

Conclusion

The combined multiparametric MRI model incorporating T1HBP, TLRR2*and TBil provides a noninvasive approach for predicting high proliferative activity in HCC, representing a promising tool for preoperative risk stratification and personalized treatment planning.

Schlagwörter

Stichwörter der Autor:innen

Ki-67biomarkershepatocellular carcinomamagnetic resonance imagingprognosistumor microenvironment

Autor:innen und Institutionen

  • Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

ORCID-Profile: Yaqi Shen, Xuemei Hu, Zhen Li

Zitieren

APA

Zhang, F., Chen, G., Huang, M., Yang, Y., Wang, Z., Shen, Y., Luo, Y., Hu, X., & Li, Z. (2026). Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s574222

Vancouver

Zhang F, Chen G, Huang M, Yang Y, Wang Z, Shen Y, et al. Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s574222

BibTeX
@article{Zhang2026,
  author = {Zhang, Fan and Chen, Gen and Huang, Mengqi and Yang, Yang and Wang, Zixiong and Shen, Yaqi and Luo, Yan and Hu, Xuemei and Li, Zhen},
  title = {Noninvasive Prediction of High Ki-67 Expression in Hepatocellular Carcinoma Using Multiparametric MRI and Clinical Biomarkers},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--14},
  doi = {10.2147/jhc.s574222}
}
Kostenlos starten →